Scholars Central

Conference abstract

BDH2 is a poor novel independent maker in CN-AML

Authors: Wen-Chi Yang, Wan-Chi Tsai, Shu-Chen Wang, Sheng-Fung Lin, Pai-Mei Lin

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The relevance of recurrent molecular abnormalities in cytogenetically normal (CN) acute myeloid leukemia (AML) was recently acknowledged by the inclusion of molecular markers such as NPM1, FLT3, and CEBPA as a complement to cytogenetic information within both the World Health Organization and the European Leukemia Net classifications. Mitochondrial metabolism is different in cancer and normal cells. A novel cytosolic type 2-hydroxybutyrate dehydrogenase, BDH2, originally named DHRS6, plays a physiological role in the cytosolic utilization of ketone bodies, which can subsequently enter mitochondria and the tricarboxylic acid cycle. Moreover, BDH2 catalyzes the production of 2,3-DHBA during enterobactin biosynthesis and participates in 24p3 (LCN2)-mediated iron transport and apoptosis. We observed that BDH2 expression is an independent poor prognostic factor for CN-AML, with an anti-apoptotic role. Patients with high BDH2 expression have relatively shorter overall survival (P=0.007) and a low complete response rate (P=0.032). BDH2-knockdown (BDH2-KD) in THP1 and HL60 cells increased the apoptosis rate under reactive oxygen species stimulation. Decrease inducible survivin, a member of the inhibitors of apoptosis family, but not members of the Bcl-2 family, induced apoptosis via a caspase-3- independent pathway upon BDH2-KD. Additionally, under cell cycle analysis, surface markers and special stain studies, we noticed that BDH2-KD induced differentiation and decreased the growth rate of THP1 cells, which was associated with the retardation of cell cycle. Here, we present a novel gene, BDH2, as an independent poor prognostic marker for CN-AML, with the role of anti-apoptosis, through surviving, and the role influence on cell cycle arrest and differentiation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Stem Cell Research & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Stem Cell Research & Therapy
  • SubjectGenetics & Molecular Biology
  • BylineArticles whose byline prints “Wen-Chi Yang”
  • BylineArticles whose byline prints “Wan-Chi Tsai”
  • BylineArticles whose byline prints “Shu-Chen Wang”
  • BylineArticles whose byline prints “Sheng-Fung Lin”
  • BylineArticles whose byline prints “Pai-Mei Lin”